Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1430Carcinoma, Renal Cell 587Urinary Bladder Neoplasms 369Kidney Neoplasms 257Carcinoma, Transitional Cell 193Neoplasm Metastasis 164Neoplasms 126Melanoma 83Breast Neoplasms 80Carcinoma, Non-Small-Cell Lung 78Testicular Neoplasms 67Ovarian Neoplasms 63Sarcoma 55Non-Muscle Invasive Bladder Neoplasms 52Urethral Neoplasms 51Wilms Tumor 49Lung Neoplasms 45Colorectal Neoplasms 45Uterine Cervical Neoplasms 40Neuroblastoma 39Pancreatic Neoplasms 38Penile Neoplasms 37Urologic Neoplasms 34Recurrence 32Lymphoma, Non-Hodgkin 32Ureteral Neoplasms 28Osteosarcoma 28Head and Neck Neoplasms 27Testicular Germ Cell Tumor 26Small Cell Lung Carcinoma 26

Interventions

danusertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Metastatic Hormone Refractory Prostate Cancer × Genitourinary × Clear all
NCT00766324 2014-05-28

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

Nerviano Medical Sciences

Phase 2 Completed
118 enrolled
Genitourinary

Metastatic Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡